Philochem AG (a company of the Philogen group) announces the completion of central radiolabeling activities for the therapeutic use of OncoFAP-23 by Lisa Nadal | Dec 4, 2023 | 2023See more details
Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors by Lisa Nadal | Dec 4, 2023 | 2023See more details
Recent Comments